Provided by Tiger Trade Technology Pte. Ltd.

Curanex Pharmaceuticals

4.71
-0.5600-10.63%
Post-market: 4.65-0.0600-1.27%19:30 EDT
Volume:28.57K
Turnover:142.78K
Market Cap:7.39M
PE:-0.62
High:5.38
Open:5.10
Low:4.70
Close:5.27
52wk High:183.59
52wk Low:3.58
Shares:1.57M
Float Shares:454.66K
Volume Ratio:0.60
T/O Rate:6.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5930
EPS(LYR):-3.3141
ROE:-411.08%
ROA:-225.06%
PB:1.54
PE(LYR):-1.42

Loading ...

Company Profile

Company Name:
Curanex Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
- -
Office Location:
2 Jericho Plaza,Suite 101B,Jericho,New York,United States
Zip Code:
11753
Fax:
- -
Introduction:
Curanex Pharmaceuticals Inc was originally incorporated in New York State on June 1, 2018, and later converted to a Delaware corporation. Curanex is a development-stage pharmaceutical company dedicated to discovering, developing, and commercializing innovative botanical drugs for the treatment of patients with inflammatory diseases, as well as developing therapies that may offer potential benefits to patients with unmet clinical needs in areas such as autoimmune diseases, metabolic disorders, and viral infections.

Directors

Name
Position
Jun Liu
Chairman of the Board and Chief Executive Officer and Director and President
Helen Hsu
Independent Director
Huijuan Zhong
Chief Scientific Officer and Director
Xiaohui Hao
Independent Director
Yong Yan
Independent Director

Shareholders

Name
Position
Jun Liu
Chairman of the Board and Chief Executive Officer and Director and President
Liqin Xie
Chief Operating Officer
Wanjun Zhang
Chief Financial Officer and Treasurer
Dian Ying Jing
Secretary
Huijuan Zhong
Chief Scientific Officer and Director
Ning Zhang
Chief Technology Officer